Haemonetics Corporation (HAE) to Close Braintree Plant, Move Work to Mexico, 320 Job Cuts
5/3/2013 9:02:25 AM
More...
|
Haemonetics Corporation (HAE) Completes Hemerus Medical, LLC Acquisition
5/1/2013 9:48:51 AM
More...
|
Haemonetics Corporation (HAE) Reports 4th Quarter Fiscal 2013 Revenue Up 34% and Adjusted EPS of $0.48; Fourth Quarter and Full Year Organic Revenue Up 4% and Full Year Adjusted EPS of $1.71; Completes Hemerus Medical, LLC Acquisition and Provides Fiscal 2014 Guidance
5/1/2013 6:29:33 AM
More...
|
Haemonetics Corporation (HAE) Sets Date for Investor/Analyst Meeting
4/24/2013 10:11:06 AM
More...
|
Haemonetics Corporation (HAE) Sets Date for Fourth Quarter Fiscal Year 2013 Earnings Release: Wednesday, May 1, 2013
4/2/2013 6:18:20 AM
More...
|
Haemonetics Corporation (HAE) to Present at the Raymond James Institutional Investors Conference
2/25/2013 6:36:34 AM
More...
|
Haemonetics Corporation (HAE)' CMO, Mark Popovsky, Joins U.S. Health and Human Services Advisory Committee on Blood Safety
2/14/2013 7:37:30 AM
More...
|
Haemonetics Corporation (HAE) to Present at Citi 2013 Global Healthcare Conference
2/13/2013 6:46:33 AM
More...
|
Haemonetics Corporation (HAE) to Present at Leerink Swann and Company 2013 Global Healthcare Conference
2/7/2013 6:54:07 AM
More...
|
Haemonetics Corporation (HAE) Reports 3rd Quarter Fiscal 2013 Revenue Up 29% and $0.50 Adjusted EPS; Year-to-Date Organic Revenue Up 3%; Reaffirms Fiscal 2013 Adjusted EPS Guidance of $1.65-$1.70
1/30/2013 6:36:39 AM
More...
|
|